ebselen has been researched along with Candida Infection in 3 studies
ebselen : A benzoselenazole that is 1,2-benzoselenazol-3-one carrying an additional phenyl substituent at position 2. Acts as a mimic of glutathione peroxidase.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Superficial mycoses are the fungal infections of skin, hair and nail which affect thousands of people worldwide." | 1.56 | Ebselen nanoemulgel for the treatment of topical fungal infection. ( Billack, B; Menon, S; Patel, K; Patki, M; Vartak, R, 2020) |
| "Ebselen (Eb) is an example of a repurposed drug with poor aqueous solubility which requires sophisticated delivery system such as nanoencapsulation in nanocapsules for topical application." | 1.48 | Topical delivery of ebselen encapsulated in biopolymeric nanocapsules: drug repurposing enhanced antifungal activity. ( Andes, DR; Gubernator, J; Jaromin, A; Piętka-Ottlik, M; Zarnowski, R, 2018) |
| " Therefore, the long-term administration of ebselen might be expected to induce an immunocompromised state in the host." | 1.29 | Susceptibility of mice to bacterial and fungal infections after intragastric administration of ebselen. ( Arai, M; Kuruto, R; Masayasu, H; Motohashi, T; Nozawa, R, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Vartak, R | 1 |
| Menon, S | 1 |
| Patki, M | 1 |
| Billack, B | 1 |
| Patel, K | 1 |
| Jaromin, A | 1 |
| Zarnowski, R | 1 |
| Piętka-Ottlik, M | 1 |
| Andes, DR | 1 |
| Gubernator, J | 1 |
| Nozawa, R | 1 |
| Arai, M | 1 |
| Kuruto, R | 1 |
| Motohashi, T | 1 |
| Masayasu, H | 1 |
3 other studies available for ebselen and Candida Infection
| Article | Year |
|---|---|
Ebselen nanoemulgel for the treatment of topical fungal infection.
Topics: Administration, Topical; Antifungal Agents; Azoles; Candidiasis; Chemistry, Pharmaceutical; Drug Car | 2020 |
Topical delivery of ebselen encapsulated in biopolymeric nanocapsules: drug repurposing enhanced antifungal activity.
Topics: Administration, Topical; Antifungal Agents; Azoles; Biopolymers; Candida albicans; Candidiasis; Drug | 2018 |
Susceptibility of mice to bacterial and fungal infections after intragastric administration of ebselen.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Azoles; Body Weight; Calcitriol; Candidiasis; Carc | 1996 |